Understanding Transcobalamin II Deficiency
At a Glance
Transcobalamin II deficiency is a rare inherited disorder that prevents vitamin B12 from reaching cells normally. Early, consistent high-dose B12 injections can improve blood and immune function and support brain development, while blood tests help guide ongoing care.
Receiving a diagnosis of Transcobalamin II (TCII) deficiency for your infant can feel like entering an entirely new world overnight. It is a diagnosis that brings both a sense of relief—finally having a name for your child’s symptoms—and a significant amount of uncertainty. This condition is exceptionally rare, with a very small number of cases reported in medical literature (a 2021 case report noted fewer than 50 identified at that time) [1][2]. Because it is so rare, your local pediatrician or family doctor may never have seen a case before, which is why your child’s care will be led by a specialized team of metabolic genetics experts [3].
The “Locked Door” to Vitamin B12
To understand TCII deficiency, it helps to think of Vitamin B12 (also called cobalamin) as a vital fuel that every cell in the body needs to function. In most people, a “taxi” protein called Transcobalamin II picks up B12 from the blood and delivers it directly into the cells [4].
In children with TCII deficiency, this taxi protein is either missing or doesn’t work correctly because of a change in the TCN2 gene [5]. Even if your child’s blood contains plenty of Vitamin B12 from milk or formula, the B12 cannot get inside the cells where it is needed [6]. It is like having a house full of food, but the door is locked and the key is missing. Because the cells are “starving” for B12, the body cannot perform essential tasks, such as building healthy blood cells, supporting the immune system, or developing the brain and nervous system [7][8].
Why This Diagnosis Is Overwhelming
As a parent, you are likely navigating a whirlwind of complex emotions. It is common to feel:
- Isolation: Since TCII deficiency is an autosomal recessive disorder (meaning both parents carry a copy of the gene change), you might feel a heavy sense of responsibility or feel isolated because you don’t know any other families going through this [9][10].
- Anxiety and Uncertainty: Many parents of children with rare metabolic conditions report high levels of stress regarding their child’s future and the daily demands of medical care [11].
- Frustration with the Medical System: You may find yourself explaining your child’s condition to ER doctors or nurses who are unfamiliar with it, which can make you feel vulnerable [12].
It is important to remember that these feelings are a normal response to an extraordinary situation. You are not just a parent; you are becoming a highly skilled advocate for your child.
The Importance of Early Intervention
The “course” or progression of TCII deficiency depends heavily on how early the diagnosis is made and how aggressively it is treated.
- When Treated Early (Before 6 Months): Observations from small case series show that infants who begin receiving high-dose B12 injections early (such as before six months of age) generally have much better outcomes [4]. Early treatment supports biochemical and immune recovery and allows the blood counts to normalize [13]. Most importantly, early and consistent treatment is the best way to support healthy brain development, though six months is an approximate observation rather than a guaranteed cutoff [4].
- When Treatment is Delayed: If the condition is not caught early, the “cellular starvation” of B12 can lead to serious complications. These may include megaloblastic anemia (large, poorly functioning red blood cells), frequent infections due to a weakened immune system, and neurologic impairment, such as delays in walking or speaking [8][14]. Treatment can still be beneficial after a delayed diagnosis, but some neurologic effects may persist.
Managing the Journey
The primary treatment for TCII deficiency is bypassing the broken “taxi” system by giving high doses of B12—usually through intramuscular injections [13]. This floods the body with enough B12 that some of it can find its way into the cells through other routes.
Your medical team will use two main markers in the blood to help track how well the treatment is working: methylmalonic acid (MMA) and homocysteine [2]. When these levels are high, it means the cells are still “hungry” for B12. When the levels drop, it is a sign that the “door” is being unlocked and the cells are getting the fuel they need [2]. MMA and homocysteine are important functional markers, but they are not direct measurements of brain delivery and can be affected by other factors. Consistent monitoring of these levels with individualized targets, along with regular check-ups with a neurologist, is the standard of care to ensure your child remains on the healthiest possible path [4].
Common questions in this guide
What is transcobalamin II deficiency in a baby?
Why does my child need B12 injections if the blood level is normal?
How important is starting treatment early?
What do MMA and homocysteine results mean?
What problems can happen if TCII deficiency is treated late?
Which specialists should care for a child with TCII deficiency?
Get notified when new evidence is published on Transcobalamin deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Transcobalamin II deficiency in twins with a novel variant in the TCN2 gene: case report and review of literature.
Kose E, Besci O, Gudeloglu E, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(11)):1487-1499.
PMID: 32841161 - 2
Intramuscular Vitamin B12 Treatment in Transcobalamin II Deficiency: Case Series Clinical Outcomes.
Sawlan AM, Alotaibi M, Alharbi RM, et al.
The application of clinical genetics 2025; (18()):73-80 doi:10.2147/TACG.S519631.
PMID: 40496011 - 3
Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey.
Chow AJ, Pugliese M, Tessier LA, et al.
The patient 2022; (15(2)):171-185 doi:10.1007/s40271-021-00538-8.
PMID: 34282509 - 4
New data supporting that early diagnosis and treatment are possible and necessary in intracellular cobalamin depletion: the case of transcobalamin II deficiency.
Verónica B, Crespo C, Lochner N, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(4)):380-386 doi:10.1515/jpem-2023-0577.
PMID: 38436354 - 5
Unraveling the mystery: Exploring a case of prolonged fever and hidden genetics: Case report.
Jamil SF, Alhawsawi KI, Alrefaei SM
Journal of family medicine and primary care 2025; (14(5)):2065-2069 doi:10.4103/jfmpc.jfmpc_1839_24.
PMID: 40547723 - 6
Transcobalamin II Deficiency in Four Cases with Novel Mutations.
Ünal Ş, Rupar T, Yetgin S, et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology 2015; (32(4)):317-22 doi:10.4274/tjh.2014.0154.
PMID: 25914105 - 7
Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.
Lacombe V, Lenaers G, Urbanski G
Nutrients 2022; (14(10)) doi:10.3390/nu14102058.
PMID: 35631199 - 8
Different Presentations of Patients with Transcobalamin II Deficiency: A Single-Center Experience from Turkey
Ünal S, Karahan F, Arıkoğlu T, et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology 2019; (36(1)):37-42 doi:10.4274/tjh.galenos.2018.2018.0230.
PMID: 30185401 - 9
The supportive care needs of parents with a child with a rare disease: results of an online survey.
Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ
BMC family practice 2016; (17()):88 doi:10.1186/s12875-016-0488-x.
PMID: 27439905 - 10
"Progressive myoclonic ataxia and developmental/epileptic encephalopathy associated with a novel homozygous mutation in TCN2 gene".
Oshi MAM, Alfaifi J, Alqahtani YAM, et al.
Molecular genetics & genomic medicine 2024; (12(1)):e2282 doi:10.1002/mgg3.2282.
PMID: 37800653 - 11
The impacts of caring for children with inherited metabolic diseases for families: a cross-sectional study.
Chow AJ, Jordan I, Pallone N, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42271415 - 12
Experiences of caregivers of children with inherited metabolic diseases: a qualitative study.
Siddiq S, Wilson BJ, Graham ID, et al.
Orphanet journal of rare diseases 2016; (11(1)):168 doi:10.1186/s13023-016-0548-2.
PMID: 27927250 - 13
Identification of transcobalamin deficiency with two novel mutations in the TCN2 gene in a Chinese girl with abnormal immunity: a case report.
Zhan S, Cheng F, He H, et al.
BMC pediatrics 2020; (20(1)):460 doi:10.1186/s12887-020-02357-6.
PMID: 33023511 - 14
From Pancytopenia to Hyperleukocytosis, an Unexpected Presentation of Immune Reconstitution Inflammatory Syndrome in an Infant with Methylmalonic Acidemia.
Sassine S, Remy A, Demaret T, et al.
Children (Basel, Switzerland) 2024; (11(8)) doi:10.3390/children11080990.
PMID: 39201925
This page is for educational purposes about TCII deficiency and does not replace medical advice. Your child's metabolic genetics team should interpret test results and set the B12 injection and monitoring plan.